trevogrumab muscle loss

Regeneron weight-loss drug halves muscle loss in combination with Novo's semaglutide in trial — Photo by Pilan Filmes on Pexe

The New Science Fighting Semaglutide Muscle Waste

In a recent Phase 2 trial, participants on the semaglutide-trevogrumab combo lost an average of 13% of their total weight as fat-free mass, compared with 25% on semaglutide alone. This shows the combination reduces muscle loss while enhancing fat loss, offering a more balanced weight-loss outcome. Medical Disclaimer: This article